These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10890450)

  • 1. Gigantism in mice lacking suppressor of cytokine signalling-2.
    Metcalf D; Greenhalgh CJ; Viney E; Willson TA; Starr R; Nicola NA; Hilton DJ; Alexander WS
    Nature; 2000 Jun; 405(6790):1069-73. PubMed ID: 10890450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knock your SOCS off!
    Leroith D; Nissley P
    J Clin Invest; 2005 Feb; 115(2):233-6. PubMed ID: 15690080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
    Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone mineral density in SOCS-2-deficient mice.
    Lorentzon M; Greenhalgh CJ; Mohan S; Alexander WS; Ohlsson C
    Pediatr Res; 2005 Feb; 57(2):223-6. PubMed ID: 15585682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b).
    Greenhalgh CJ; Bertolino P; Asa SL; Metcalf D; Corbin JE; Adams TE; Davey HW; Nicola NA; Hilton DJ; Alexander WS
    Mol Endocrinol; 2002 Jun; 16(6):1394-406. PubMed ID: 12040024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease.
    Diamond P; Doran P; Brady HR; McGinty A
    J Nephrol; 2000; 13(1):9-14. PubMed ID: 10720209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressors of cytokine signalling and regulation of growth hormone action.
    Greenhalgh CJ; Alexander WS
    Growth Horm IGF Res; 2004 Jun; 14(3):200-6. PubMed ID: 15125881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of "suppressor of cytokine signalling" (SOCS) genes in the developing and adult mouse nervous system.
    Polizzotto MN; Bartlett PF; Turnley AM
    J Comp Neurol; 2000 Jul; 423(2):348-58. PubMed ID: 10867663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling.
    Greenhalgh CJ; Metcalf D; Thaus AL; Corbin JE; Uren R; Morgan PO; Fabri LJ; Zhang JG; Martin HM; Willson TA; Billestrup N; Nicola NA; Baca M; Alexander WS; Hilton DJ
    J Biol Chem; 2002 Oct; 277(43):40181-4. PubMed ID: 12208853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor.
    Dey BR; Spence SL; Nissley P; Furlanetto RW
    J Biol Chem; 1998 Sep; 273(37):24095-101. PubMed ID: 9727029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins.
    Ahmed SF; Farquharson C
    J Endocrinol; 2010 Sep; 206(3):249-59. PubMed ID: 20631046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seeking SOCS and sex steroids.
    Waters MJ
    Trends Endocrinol Metab; 2003; 14(4):149-51. PubMed ID: 12714271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia.
    Masters SL; Palmer KR; Stevenson WS; Metcalf D; Viney EM; Sprigg NS; Alexander WS; Nicola NA; Nicholson SE
    Mol Cell Biol; 2005 Jul; 25(13):5639-47. PubMed ID: 15964819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1.
    Starr R; Metcalf D; Elefanty AG; Brysha M; Willson TA; Nicola NA; Hilton DJ; Alexander WS
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14395-9. PubMed ID: 9826711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet effects on female reproduction in high growth (hg/hg) mice that are deficient in the Socs-2 gene.
    Corva PM; Mucci NC; Evans K; Medrano JF
    Reprod Nutr Dev; 2004; 44(4):303-12. PubMed ID: 15535462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Signal transduction of JAK-STAT pathway].
    Omura T; Yoshiyama M; Yoshikawa J
    Nihon Rinsho; 2000 Jan; 58 Suppl 1():206-9. PubMed ID: 11026265
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel trap for dynamic protein interactions in cytokine signaling.
    Brock A; Huang S
    Trends Biotechnol; 2002 Apr; 20(4):145. PubMed ID: 11906744
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyanocobalamin prevents cardiomyopathy in type 1 diabetes by modulating oxidative stress and DNMT-SOCS1/3-IGF-1 signaling.
    Kakoki M; Ramanathan PV; Hagaman JR; Grant R; Wilder JC; Taylor JM; Charles Jennette J; Smithies O; Maeda-Smithies N
    Commun Biol; 2021 Jun; 4(1):775. PubMed ID: 34163008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
    Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
    J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.